..............page:1214-1215,1219
..............page:1269-1272
..............page:1257,1289
..............page:1242-1244
..............page:1207-1210
..............page:1232,1192
..............page:1238-1240
..............page:1216-1219
..............page:1211-1213
..............page:1275-1277
..............page:1247-1248
..............page:1224-1227
..............page:1282-1284
..............page:1258-1259
..............page:1236-1238
..............page:1254-1255
..............page:1286-1288
..............page:1244-1245
..............page:1228-1232,1192
..............page:1246-1247
..............page:1266-1269
..............page:1200-1203
..............page:1285-1286
..............page:1197-1199
..............page:1240-1241
..............page:1196,1199
..............page:1264,1289
..............page:1249-1250
..............page:1259-1261
..............page:1262-1263,1289
..............page:1251-1252
..............page:1233-1235,1192
..............page:1278-1282
..............page:1220-1223
Safety and efficiency of dalteparin during percutaneous coronary intervention
SHI Xu-bo1;HU Da-yi2;LI Tian-chan3;MA Zhi-min1;WANG Guo-hong1;WANG Ji-yun1 1.Center of Cardiology;Beijing Tongren Hospital affiliated to Beijing Medical University;Beijing 100730;China;2.Center of Cardiology;People’s Hospital of Beijing University;Beijing 100044;China;3.Department of Cardiology;Beijing Corps Hospital;Beijing 100039;China
..............page:1204-1206,1210
..............page:1273-1275